313 related articles for article (PubMed ID: 9473953)
1. The burden of viral hepatitis in Africa.
Bojuwoye BJ
West Afr J Med; 1997; 16(4):198-203. PubMed ID: 9473953
[TBL] [Abstract][Full Text] [Related]
2. The liver in HIV in Africa.
Feld JJ; Ocama P; Ronald A
Antivir Ther; 2005; 10(8):953-65. PubMed ID: 16430201
[TBL] [Abstract][Full Text] [Related]
3. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
4. [Estimation on disease burden related to hepatitis B virus infection in Shandong province of China].
Qi WT; Sun JD; Xu AQ; Zhang L; Li RP; Ma JX; Guo XL; Fan QY; Yang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jul; 30(7):679-83. PubMed ID: 19957589
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis B and C in Egypt and Africa.
Attia MA
Antivir Ther; 1998; 3(Suppl 3):1-9. PubMed ID: 10726051
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation.
Burnett RJ; François G; Kew MC; Leroux-Roels G; Meheus A; Hoosen AA; Mphahlele MJ
Liver Int; 2005 Apr; 25(2):201-13. PubMed ID: 15780040
[TBL] [Abstract][Full Text] [Related]
7. How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore.
Ong SC; Lim SG; Li SC
J Viral Hepat; 2009 Jan; 16(1):53-63. PubMed ID: 19192158
[TBL] [Abstract][Full Text] [Related]
8. [Incidence of various types of viral hepatitis and its sequelae throughout the world].
Szata W
Przegl Epidemiol; 1989; 43(3):241-9. PubMed ID: 2515559
[TBL] [Abstract][Full Text] [Related]
9. Viral hepatitis in India.
Acharya SK; Madan K; Dattagupta S; Panda SK
Natl Med J India; 2006; 19(4):203-17. PubMed ID: 17100109
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B vaccines.
Zuckerman AJ
Postgrad Med J; 1986; 62 Suppl 2():3-10. PubMed ID: 2959911
[TBL] [Abstract][Full Text] [Related]
11. [WHO spearheads global initiative to eradicate hepatitis B].
Sylvan S
Lakartidningen; 2000 Aug; 97(35):3738-40. PubMed ID: 11016226
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis B surface antigen among patients suspected of liver diseases in a Nigerian hospital.
Baba MM; Ajayi BB; Ekanem IA
Niger Postgrad Med J; 2000 Sep; 7(3):91-5. PubMed ID: 11257921
[TBL] [Abstract][Full Text] [Related]
13. Current views on liver diseases in Ethiopia.
Tsega E
Ethiop Med J; 1977 Apr; 15(2):75-82. PubMed ID: 201462
[TBL] [Abstract][Full Text] [Related]
14. Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain.
Idris BI; Brosa M; Richardus JH; Esteban R; Schalm SW; Buti M
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):320-6. PubMed ID: 18334876
[TBL] [Abstract][Full Text] [Related]
15. "Just Another Statistic".
Machtay M; Glatstein E
Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam.
Kakumu S; Sato K; Morishita T; Trinh KA; Nguyen HB; Banh VD; Do HC; Nguyen HP; Nguyen VT; Le TT; Yamamoto N; Nakao H; Isomura S
J Med Virol; 1998 Apr; 54(4):243-8. PubMed ID: 9557289
[TBL] [Abstract][Full Text] [Related]
17. Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis.
Frieden TR; Ozick L; McCord C; Nainan OV; Workman S; Comer G; Lee TP; Byun KS; Patel D; Henning KJ
Hepatology; 1999 Mar; 29(3):883-8. PubMed ID: 10051493
[TBL] [Abstract][Full Text] [Related]
18. [Seroprevalence of hepatitis B and C viruses in a psychiatric institution].
Eveillard M; Daroukh A; Desjardins P; Legrand S; Odzo-Gakala M; Bourlioux P
Pathol Biol (Paris); 1999 May; 47(5):543-8. PubMed ID: 10418037
[TBL] [Abstract][Full Text] [Related]
19. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa.
Sathar MA; Soni PN; Naicker S; Conradie J; Lockhat F; Gouws E
J Med Virol; 1999 Sep; 59(1):38-44. PubMed ID: 10440806
[TBL] [Abstract][Full Text] [Related]
20. [Active immunoprophylaxis of type B viral hepatitis. Evaluation of the effectiveness of HEVAC-B vaccine in a population at risk].
Tarocco RP; Faro G; Sargiotto A; Visconti C
Minerva Med; 1987 Aug; 78(16):1233-41. PubMed ID: 2957614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
